Improving Sleep for Chronic Pain
Trial Summary
What is the purpose of this trial?
The goal of this study is to test two behavioral interventions for chronic insomnia in individuals with chronic pain and use prescribed opioid medication to treat their chronic pain.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it allows medications prescribed for pain or sleep. You should have a written agreement from your doctor if you are on opioid medication.
What data supports the effectiveness of the treatment CBT-I for improving sleep in patients with chronic pain?
Research shows that CBT-I (Cognitive Behavioral Therapy for Insomnia) can lead to meaningful improvements in sleep for people with both insomnia and chronic pain. While the effects on pain are less consistent, CBT-I has been found to improve sleep quality and duration, even in the presence of ongoing pain.12345
Is Cognitive Behavioral Therapy for Insomnia (CBT-I) safe for humans?
How is CBT-I treatment different from other treatments for chronic pain?
CBT-I (Cognitive Behavioral Therapy for Insomnia) is unique because it focuses on improving sleep habits and changing negative thoughts about sleep, which can lead to better sleep quality and efficiency in people with chronic pain. Unlike other treatments that may focus directly on pain relief, CBT-I targets insomnia, which is a common issue in chronic pain patients, and has shown to improve sleep and sometimes pain-related functioning.134811
Research Team
Christina S McCrae, PhD
Principal Investigator
University of South Florida
Eligibility Criteria
This trial is for people who have chronic pain and insomnia, and are currently using prescribed opioids. It aims to help them sleep better and reduce their opioid use.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 8 weeks of online CBT-I (1 session/week for 1 hour), followed by tapered withdrawal and motivational interviewing and check-ins
Tapered Withdrawal
Participants undergo a gradual tapering of opioid medication with motivational interviewing and check-ins
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments at 6 months
Treatment Details
Interventions
- CBT-I
CBT-I is already approved in United States, European Union, Canada for the following indications:
- Chronic insomnia
- Insomnia in individuals with chronic pain
- Insomnia in individuals with psychiatric comorbidities
- Chronic insomnia
- Insomnia in individuals with chronic pain
- Insomnia in individuals with psychiatric comorbidities
- Chronic insomnia
- Insomnia in individuals with chronic pain
- Insomnia in individuals with psychiatric comorbidities
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of South Florida
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
National Institutes of Health (NIH)
Collaborator